When was Skyclarys approved by the FDA?

Lindsey Shapiro, PhD avatar

by Lindsey Shapiro, PhD |

Share this article:

Share article via email
A

When was Skyclarys approved by the FDA?

Category: Skyclarys

Skyclarys was approved by the U.S. Food and Drug Administration (FDA) in February 2023 for adults and adolescents, ages 16 and older, with Friedreich’s ataxia. The FDA’s approval made Skyclarys the first and only therapy for the disease in the U.S.

Print This Page

About the Author

Lindsey Shapiro, PhD avatar
Lindsey Shapiro, PhD Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.

Recent Posts


Recommended reading